Literature DB >> 34022039

Predicting neurological recovery after traumatic spinal cord injury by time-resolved analysis of monocyte subsets.

Raban Arved Heller1,2,3, Julian Seelig1, Helena Lucia Crowell4,5, Maximilian Pilz6, Patrick Haubruck2,7, Qian Sun1, Lutz Schomburg1, Volker Daniel8, Arash Moghaddam9, Bahram Biglari10.   

Abstract

Monocytes and lymphocytes elicit crucial activities for the regenerative processes after various types of injury. The survival of neurons exposed to mechanical and oxidative stress after traumatic spinal cord injury depends on a multitude of factors. In this study, we sought to evaluate a correlation between remission after traumatic spinal cord injury and the dynamics of monocyte subsets in respect to the lymphocytes' responsive potential, cytokine expression, patterns of trace element concentration and clinical covariates. We examined prospectively 18 (three female, 15 male) patients after traumatic spinal cord injury. Blood samples were drawn at admission and 4 h, 9 h, 12 h, 1 and 3 days as well as 1 and 2 weeks and 1, 2 and 3 months after the trauma. Analysis of cytokines (CCL2, IL-10, enolase 2, CXCL12, TGF-β1, TGF-β2) was performed using a multiplex cytokine panel. Plasma trace element concentrations of selenium, copper and zinc were determined by total reflection X-ray fluorescence analysis; neopterin, selenoprotein P (SELENOP) and ceruloplasmin (CP) by enzyme-linked immunosorbent assay; and selenium binding protein 1 (SELENBP1) by luminometric immunoassay. The responsive potential of lymphocytes was assessed using transformation tests. The monocyte subsets (classical, intermediate, and non-classical) and expression of CD14, CD16, CXCR4 and intracellular IL-10 were identified using a multi-colour flow cytometry analysis. The dynamics of the cluster of intermediate CD14-/CD16+/IL10+/CXCR4int monocytes differed significantly between patients with an absence of neurological remission (G0) from those with an improvement (G1) by 1 or 2 American Spinal Injury Association Impairment Scale (AIS) steps (Kruskal-Wallis Test, P = 0.010, G0 < G1, AIS+: 1 < G1, AIS+: 2) in the first 24 h. These dynamics were associated inversely with an increase in enolase and SELENBP1 14 days after the injury. In the elastic net regularized model, we identified an association between the increase of a subpopulation of intermediate CD14-/CD16+/IL10+/CXCR4int monocytes and exacerbated immune response within 24 h after the injury. These findings were reflected in the consistently elevated response to mitogen stimulation of the lymphocytes of patients with significant neurological remission. Early elevated concentrations of CD14-/CD16+/IL10+/CXCR4int monocytes were related to higher odds of CNS regeneration and enhanced neurological remission. The cluster dynamics of CD14-/CD16+/IL10+/CXCR4int monocytes in the early-acute phase after the injury revealed a maximum of prognostic information regarding neurological remission (mean parameter estimate: 0.207; selection count: 818/1000 repetitions). We conclude that early dynamics in monocyte subsets allow a good prediction of recovery from traumatic spinal cord injury.
© The Author(s) (2021). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  biomarker; flow cytometry; monocytes; recovery; spinal cord injury

Mesh:

Substances:

Year:  2021        PMID: 34022039     DOI: 10.1093/brain/awab203

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  2 in total

Review 1.  Advancements in our understanding of circular and long non-coding RNAs in spinal cord injury.

Authors:  Yan Zhang; Ho Jun Yun; Yu Ji; Eric Cosky; Wen-Xiu Zhang; Wei Han; Yu-Chuan Ding
Journal:  Neural Regen Res       Date:  2022-11       Impact factor: 6.058

2.  Catalpol as a Component of Rehmannia glutinosa Protects Spinal Cord Injury by Inhibiting Endoplasmic Reticulum Stress-Mediated Neuronal Apoptosis.

Authors:  Zhiyang Huang; Jiahong Gong; Wen Lin; Zhiyi Feng; Yirou Ma; Yurong Tu; Xiong Cai; Jianhua Liu; Chang Lv; Xinru Lv; Qiuji Wu; Wenjie Lu; Juan Zhao; Yibo Ying; Shengcun Li; Wenfei Ni; Haili Chen
Journal:  Front Pharmacol       Date:  2022-07-08       Impact factor: 5.988

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.